All articles tagged with #chondrocytes
Stanford researchers showed that inhibiting the aging-related enzyme 15-PGDH reverses cartilage aging in mice, regenerating cartilage and improving gait; human knee tissue also exhibits regeneration signs, suggesting a potential new osteoarthritis therapy with clinical trials possible within 18 months, and crucially without relying on stem cells.
A new study indicates semaglutide may repair osteoarthritis damage by reprogramming cartilage-cell energy metabolism via the GLP-1R–AMPK–PFKFB3 axis, with mouse data showing protection beyond weight loss and a small human trial (HA + semaglutide) reporting reduced pain and thicker cartilage—suggesting a weight-loss–independent mechanism that requires further clinical validation.
Researchers have identified the voltage-gated sodium channel Nav1.7 as a key regulator in chondrocytes, the cells that maintain cartilage, and its role in the progression of osteoarthritis (OA). Nav1.7 was found to be significantly upregulated in OA-affected cartilage and contributes to OA pain. By blocking Nav1.7 in chondrocytes, joint deterioration was reduced, suggesting that targeting Nav1.7 could be a promising therapeutic strategy for treating OA and associated pain. This discovery opens new avenues for disease-modifying treatments in a condition that currently lacks effective interventions.